Mass Drug Administration: Clinical Trials

5 trials of Mass Drug Administration, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting. 4 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Recruiting 1
Phase 31Recruiting 1

Follow Mass Drug Administration: new trials by email Literature Review of Mass Drug Administration trials Research Report on Mass Drug Administration

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Expanding Access to Preventive Chemotherapy Among Mobile and Migrant Populations
Modified Mass Administration of Medicines Strategy, Albendazole 400 mg, Praziquantel 40 mg/kg - Onchocerciasis (River Blindness), Schistosomiasis
Not applicableRecruitingUwemedimo Friday Ekpo57602026-07-012026-07-16
Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness
Pre-screening Phase, Screenig Phase, Randomization - Soil-Transmitted Helminths
Phase 3RecruitingInsud Pharma200002025-09-012025-09-15
Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar
MDA with DHAp and SLD Primaquine - Malaria, Plasmodium Infections
Not applicableCompletedUlrika Morris225002016-04-302017-10-05
Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?
Mass drug administration, praziquantel 10mg/kg, Health education - Taenia Solium Infection
Not applicableCompletedInstitute of Tropical Medicine, Belgium29002016-03-012023-03-01
Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia
MDA with DHAp (Eurartesim), Focal MDA with DHAp (Eurartesim) - Malaria, Malaria, Falciparum
Not applicableCompletedPATH24302014-09-012020-09-16

Conditions studied

Malaria (2)  ·  Elephantiasis, Filarial (1)  ·  Hookworm Infections (1)  ·  Infections (1)  ·  Malaria, Falciparum (1)  ·  Neglected Diseases (1)  ·  Onchocerciasis (1)  ·  Onchocerciasis, Ocular (1)  ·  Schistosomiasis (1)  ·  Taeniasis (1)

Sponsors

Institute of Tropical Medicine, Belgium (1)  ·  Insud Pharma (1)  ·  PATH (1)  ·  Ulrika Morris (1)  ·  Uwemedimo Friday Ekpo (1)

Countries

Zambia (2)  ·  Ghana (1)  ·  Kenya (1)  ·  Nigeria (1)  ·  Tanzania (1)

Top investigators

Abdullah S Ali, Programme Manager (1)  ·  Alejandro Krolewiecki, MD (1)  ·  Emmanuel Bottieau, PhD, MD (1)  ·  Hammed Mogaji, PhD (1)  ·  John M Miller, PhD (1)  ·  Pierre Dorny, PhD (1)  ·  Uwem Ekpo, PhD (1)

Results publications

PMID 34585740, PMID 30526588